procainamide has been researched along with Carcinoma, Oat Cell in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giannone, L | 1 |
| Kugler, JW | 1 |
| Krantz, SB | 1 |
1 other study available for procainamide and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Pure red cell aplasia associated with administration of sustained-release procainamide.
Topics: Aged; Anemia, Aplastic; Carcinoma, Small Cell; Delayed-Action Preparations; Drug Therapy, Combinatio | 1987 |